Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature

Ventilator-associated pneumonia (VAP) in critically ill patients with COVID-19 represents a very huge global threat due to a higher incidence rate compared to non-COVID-19 patients and almost 50% of the 30-day mortality rate. Pseudomonas aeruginosa was the first pathogen involved but uncommon non-fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Burastero, Giulia Jole, Orlando, Gabriella, Santoro, Antonella, Menozzi, Marianna, Franceschini, Erica, Bedini, Andrea, Cervo, Adriana, Faltoni, Matteo, Bacca, Erica, Biagioni, Emanuela, Coloretti, Irene, Melegari, Gabriele, Maccieri, Jessica, Busani, Stefano, Bertellini, Elisabetta, Girardis, Massimo, Ferrarini, Giulia, Rofrano, Laura, Sarti, Mario, Mussini, Cristina, Meschiari, Marianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330655/
https://www.ncbi.nlm.nih.gov/pubmed/35892396
http://dx.doi.org/10.3390/antibiotics11081007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330655/
https://www.ncbi.nlm.nih.gov/pubmed/35892396
http://dx.doi.org/10.3390/antibiotics11081007

Ejemplares similares